Intrust Bank’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,772
| Closed | -$272K | – | 391 |
|
|
2020
Q4 | $272K | Sell |
3,772
-859
| -19% | -$45K | 0.04% | 307 |
|
|
2020
Q3 | $211K | Sell |
4,631
-2,635
| -36% | -$110K | 0.04% | 317 |
|
|
2020
Q2 | $328K | Buy |
7,266
+242
| +3% | +$10.8K | 0.07% | 252 |
|
|
2020
Q1 | $270K | Sell |
7,024
-930
| -12% | -$42.8K | 0.08% | 250 |
|
|
2019
Q4 | $368K | Sell |
7,954
-284
| -3% | -$12.3K | 0.08% | 233 |
|
|
2019
Q3 | $335K | Sell |
8,238
-1,630
| -17% | -$70.4K | 0.08% | 248 |
|
|
2019
Q2 | $475K | Sell |
9,868
-3,751
| -28% | -$197K | 0.12% | 202 |
|
|
2019
Q1 | $853K | Sell |
13,619
-924
| -6% | -$63.5K | 0.22% | 117 |
|
|
2018
Q4 | $869K | Sell |
14,543
-382
| -3% | -$22.9K | 0.25% | 92 |
|
|
2018
Q3 | $962K | Sell |
14,925
-237
| -2% | -$13.2K | 0.24% | 102 |
|
|
2018
Q2 | $682K | Buy |
15,162
+1,639
| +12% | +$65.4K | 0.19% | 145 |
|
|
2018
Q1 | $420K | Buy |
13,523
+5,545
| +70% | +$182K | 0.12% | 226 |
|
|
2017
Q4 | $238K | Sell |
7,978
-2,438
| -23% | -$70.6K | 0.07% | 335 |
|
|
2017
Q3 | $344K | Buy |
10,416
+2,944
| +39% | +$102K | 0.11% | 256 |
|
|
2017
Q2 | $250K | Buy |
+7,472
| New | +$223K | 0.09% | 327 |
|
Other funds holding BEAT
Intrust Bank's BEAT Position: Q1 2021 in Review
Intrust Bank sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 3,772 shares — an estimated $272K sold.
Intrust Bank first reported a position in BEAT in Q2 2017 and held it in 15 quarters. The position peaked at $962K in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Intrust Bank reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Intrust Bank sold 3,772 BioTelemetry, Inc. shares in Q1 2021, an estimated $272K.
- Intrust Bank first reported a position in BioTelemetry, Inc. in Q2 2017 and held it in 15 quarters.
- Intrust Bank's BioTelemetry, Inc. position peaked at $962K in Q3 2018.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Intrust Bank's 13F filing for Q1 2021, filed 2 Jun 2021.